Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-550-6 | CAS number: 84-66-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- short-term repeated dose toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1984
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Data from a preliminary study to select doses for a subsequent carcinogenicity study. Full range of parameters typical for repeat dose studies not examined
Data source
Referenceopen allclose all
- Reference Type:
- review article or handbook
- Title:
- Unnamed
- Year:
- 2 001
- Reference Type:
- study report
- Title:
- Unnamed
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- To evaluate the toxic effects of repeated exposure to DEP by the dermal route and to select suitable dose levels for use in subsequent 2 year studies
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Diethyl phthalate
- EC Number:
- 201-550-6
- EC Name:
- Diethyl phthalate
- Cas Number:
- 84-66-2
- Molecular formula:
- C12H14O4
- IUPAC Name:
- .
- Details on test material:
- - Name of test material (as cited in study report): diethyl phthalate
- Physical state: liquid
- Analytical purity:>99%
- Stability under test conditions: 2 weeks
- Storage condition of test material: stored in amber glass bottles protected from light at room temperature
- Other: The stability of the bulk chemical was monitored periodically using GC. No degradation of the bulk chemical occurred.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Simonsen Laboratories Inc Gilroy CA USA
- Age at study initiation: approximately 42 days
- Weight at study initiation: range of mean weights males: 20.6-21.4g; females: 15.9-16.5g
- Fasting period before study: N/A
- Housing: individual
- Diet (e.g. ad libitum): yes, NIH07 open formula meal (Zeigler Brothers, Gardeners PA USA
- Water (e.g. ad libitum): yes, by automatic system
- Acclimation period: 13 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23-24 degrees C
- Humidity (%): 28-74%
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12h
IN-LIFE DATES: From: 1984-09-05 To: 1984-10-08
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- TEST SITE
- Area of exposure: interscapular skin
- % coverage: not reported
- Type of wrap if used: N/A
REMOVAL OF TEST SUBSTANCE
- Washing (if done): not reported
- Time after start of exposure: not reported
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0, 12.5, 25, 50 or 100ul
- Concentration (if solution): 100% used as supplied
- Constant volume or concentration used: yes/no: constant concentration
- For solids, paste formed: N/A
USE OF RESTRAINERS FOR PREVENTING INGESTION: no - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Periodic analyses using reverse phase HPLC
- Duration of treatment / exposure:
- Ca 4 weeks
- Frequency of treatment:
- 5 times /w (Monday -Friday)
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 12.5, 25, 50 or 100ul
Basis:
nominal per unit area
- No. of animals per sex per dose:
- 10 males & 10 females
- Control animals:
- yes, concurrent no treatment
- Details on study design:
Animals randomly assigned to treatment groups using a computer generated randomisation procedure- Positive control:
- No
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: 2 X daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: initially then weekly thereafter
DERMAL IRRITATION (if dermal study): No
- Time schedule for examinations:
BODY WEIGHT: Yes
- Time schedule for examinations: initially then weekly thereafter - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes - complete histopathologic examinations conducted on all animals; Gross lesions, tissue masses and adrenal gland, brain, oesophagus, gall bladder , heart, kidney, lcolon, caecum, rectum, liver, lung, mammary gland, mandibular & mesenteric lymphnodes, nose, ovary, parathyroid gland, pituitary gland, prostate gland, salivary gland, seminal vesicles, skin ( site of application, control & other), duodenum, jejunum, ileum, spleen, sternum, stomach, testis, thymus, thyroid gland, trachea, urinary bladder & uterus - Other examinations:
- No
- Statistics:
- Means & SDs & Williams or Dunnetts test
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- One female in the control group died. There were no clinical signs indicative of toxicity
- Dermal irritation:
- not examined
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- One female in the control group died. There were no clinical signs indicative of toxicity
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Final mean body weights of female mice given DEP were 5-7% heavier than controls
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- Absolute & relative liver weights were greater in females given 25 & 100 ul DEP than in controls.
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not specified
- Details on results:
- CLINICAL SIGNS AND MORTALITY: No effect of treatment
BODY WEIGHT AND WEIGHT GAIN: No effect of treatment
FOOD CONSUMPTION: No effect of treatment
ORGAN WEIGHTS: Absolute & relative liver weights were greater in females given 25 & 100 ml DEP than in controls.
GROSS PATHOLOGY: No effect of treatment
HISTOPATHOLOGY: NON-NEOPLASTIC: No effect of treatment
OTHER FINDINGS: None
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 12.5 other: ul
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Increased liver weight (absolute & relative) in mice given 25 and 100 ul DEP.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study DEP applied neat to the skin of mice 5/7 days for 28 days the only effect was an increase in liver weight (absolute & relative) in those given 25 & 100 ul/31 & 123 mg. The NOAEL is considered to be 12.5 ul (15 mg).
- Executive summary:
Under the conditions of this study DEP applied neat to the skin of mice 5/7 days for 28 days the only effect was an increase in liver weight (absolute & relative) in those given 25 & 100 ul/31 & 123 mg. The NOAEL is considered to be 12.5 ul (15 mg).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.